We are a research group located at the University of New South Wales, Sydney, Australia. Our expertise lies in the development of novel (macro)molecular therapeutic agents (e.g., drugs, adjuvants) and materials (e.g., coatings) for antimicrobial, anticancer and antiviral applications.
It is clear that many global healthcare issues such as antibiotic resistance will have a detrimental effect on society if no new viable solutions are available. Driven by these challenges, our team has been working in this research area from 2016 and has since built a solid foundation of expertise (check our Publications).
Our group is not only passionate in building impactful knowledge pool but are also keen on partnering with industry to translate and develop technologies for commercial applications, either via joint grant submissions or through consultations and lab services that we offer (more info under Industry Partnerships).
Dr Edgar Wong
Edgar is currently an ARC Future Fellow and UNSW Scientia Lecturer. Graduated with a PhD from UNSW in 2011, Edgar has over 10 years of experience in polymer/organic chemistry and materials science and has been mentored by world renowned researchers. He is now focussing his research efforts on developing innovative and effective strategies to combat infectious diseases, especially on the issue of antimicrobial resistance.
Dr Shu Lam
Shu graduated with a PhD in 2016 from the University of Melbourne and is currently working for a contract research organization called IQVIA. Best known for her seminal first author work on antimicrobial peptide polymers (published in Nature Microbiology) which garnered worldwide media attention and coverage. Shu has been the pillar of support for Edgar throughout all these years.
Mr Ethan Zeyu Shao
Ethan recently obtained his Masters thesis in February 2022 and is continuing his stay at the group as a PhD candidate. He is currently working on the development of novel stimuli responsive antimicrobial and anticancer membrane-active agents.
Ms Sabah Inam
Sabah is currently pursuing a double degree in Bachelor of Chemical Engineering and Advanced Science and she is doing her honours research project with the group, developing novel antimicrobial combination therapy systems.